Myriad Genetics, Inc.MYGNNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank29
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$1.80M
↓ 87% vs avg
Percentile
P29
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$13.41M
Historical baseline
PeriodValueYoY Change
2025$1.80M+120.7%
2024$-8.70M+92.2%
2023$-110.90M-4.3%
2022$-106.30M-671.5%
2021$18.60M+169.1%
2020$-26.90M-144.3%
2019$60.70M-27.5%
2018$83.70M-27.8%
2017$115.90M+9.1%
2016$106.20M-